7345:HK CSOP Leveraged and Inverse Series II - CSOP WTI Crude Oil Futures Daily (-1x) Inverse Product

GBP 599.00 -6.00 ( -0.99%)
Icon

CSOP Leveraged and Inverse Series II - CSOP WTI Crude Oil Futures Daily (-1x) Inverse Product (7345:HK) Stock Analysis and Price Targets

COMMON STOCK | | HK
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBP 599.00

-6.00 (-0.99%)

N/A

4.60K

GBP 0.00

N/A

Icon

7345:HK

CSOP Leveraged and Inverse Series II - CSOP WTI Crude Oil Futures Daily (-1x) Inverse Product (GBP)
COMMON STOCK | HK
GBP 599.00
-6.00 ( -0.99%)

CSOP Leveraged and Inverse Series II - CSOP WTI Crude Oil Futures Daily (-1x) Inverse Product (7345:HK) Stock Forecast

N/A

Based on the CSOP Leveraged and Inverse Series II - CSOP WTI Crude Oil Futures Daily (-1x) Inverse Product stock forecast from 0 analysts, the average analyst target price for CSOP Leveraged and Inverse Series II - CSOP WTI Crude Oil Futures Daily (-1x) Inverse Product is not available over the next 12 months. CSOP Leveraged and Inverse Series II - CSOP WTI Crude Oil Futures Daily (-1x) Inverse Product’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of CSOP Leveraged and Inverse Series II - CSOP WTI Crude Oil Futures Daily (-1x) Inverse Product is Neutral, which is based on 0 positive signals and 0 negative signals. At the last closing, CSOP Leveraged and Inverse Series II - CSOP WTI Crude Oil Futures Daily (-1x) Inverse Product’s stock price was GBP 599.00. CSOP Leveraged and Inverse Series II - CSOP WTI Crude Oil Futures Daily (-1x) Inverse Product’s stock price has changed by +1.18% over the past week, +1.18% over the past month and +14,566.99% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...